Acadian Asset Management
KRRO icon

Acadian Asset Management’s Korro Bio KRRO Stock Holding History

Acadian Asset Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$471K Buy
41,825
+8,035
+24% +$88.5K ﹤0.01% 1373
2025
Q4 		$270K Buy
+33,790
New +$790K ﹤0.01% 1459
2023
Q4 		– Sell
-2,819
Closed -$50K – 1750
2023
Q3 		$50K Hold
2,819
– – ﹤0.01% 1430
2023
Q2 		$47K Hold
2,819
– – ﹤0.01% 1540
2023
Q1 		$70K Buy
+2,819
New +$321K ﹤0.01% 1463
2022
Q2 		– Sell
-227
Closed -$24K – 1774
2022
Q1 		$24K Buy
+227
New +$43.4K ﹤0.01% 1556

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Acadian Asset Management's KRRO Position: Q1 2026 in Review

Acadian Asset Management increased its Korro Bio (KRRO) stake by 24% in Q1 2026, buying an estimated $88.5K and bringing the position to 41,825 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Acadian Asset Management first reported a position in KRRO in Q1 2022 and has held it in 6 quarters since. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Acadian Asset Management held 41,825 shares of Korro Bio worth $471K as of Q1 2026.
  • Acadian Asset Management bought 8,035 Korro Bio shares in Q1 2026, an estimated $88.5K.
  • Korro Bio made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1373 holding.
  • Acadian Asset Management first reported a position in Korro Bio in Q1 2022 and has held it in 6 quarters since.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.